Fatty acid-inducible ANGPTL4 governs lipid metabolic response to exercise

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 11, 2014, Pages

  Catoire, Milène ^a   Alex, Sheril ^a   Paraskevopulos, Nicolas ^a   Mattijssen, Frits ^a   Evers Van Gogh, Inkie ^b   Schaart, Gert ^c   Jeppesen, Jacob ^d   Kneppers, Anita ^a   Mensink, Marco ^a   Voshol, Peter J ^e   Olivecrona, Gunilla ^f   Tan, Nguan Soon ^g   Hesselink, Matthijs K C ^e   Berbée, Jimmy F ^h   Rensen, Patrick C N ^h   Kalkhoven, Eric ^b   Schrauwen, Patrick ^c   Kersten, Sander ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f UMEÅ UNIVERSITY   (Sweden)

^g NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

^h LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE KINASE; ANGIOPOIETIN LIKE 4; CARNITINE TRANSPORTER 2; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR2.1; KRUPPEL LIKE FACTOR 10; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRUVATE DEHYDROGENASE KINASE 4; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VASCULOTROPIN A; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXERCISE; FATTY ACID BLOOD LEVEL; GENE CONTROL; GENOTYPE; GLYCOGEN MUSCLE LEVEL; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPID METABOLISM; MICROARRAY ANALYSIS; MUSCLE; MUSCLE BIOPSY; MUSCLE FUNCTION; MYOTUBE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ADULT; ANGIOPOIETINS; EXERCISE; FATTY ACIDS; FLUORESCENT ANTIBODY TECHNIQUE; HOMEOSTASIS; HUMANS; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; MIDDLE AGED; MUSCLE, SKELETAL;

EID: 84896532233     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1400889111     Document Type: Article

References (51)

1. Kiens B (2006) Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev 86(1):205-243.
2. Keller P, et al. (2007) Using systems biology to define the essential biological networks responsible for adaptation to endurance exercise training. Biochem Soc Trans 35(Pt 5): 1306-1309. (Pubitemid 350206486)
3. Buford TW, Cooke MB, Willoughby DS (2009) Resistance exercise-induced changes of inflammatory gene expression within human skeletal muscle. Eur J Appl Physiol 107(4):463-471.
4. Catoire M, et al. (2012) Pronounced effects of acute endurance exercise on gene expression in resting and exercising human skeletal muscle. PLoS ONE 7(11): e51066.
5. Schmutz S, et al. (2006) Endurance training modulates the muscular transcriptome response to acute exercise. Pflugers Arch 451(5):678-687. (Pubitemid 43042180)
6. Yang Y, Creer A, Jemiolo B, Trappe S (2005) Time course of myogenic and metabolic gene expression in response to acute exercise in human skeletal muscle. J Appl Physiol (1985) 98(5):1745-1752. (Pubitemid 40570785)
7. Buckley JD, Scroop GC, Catcheside PG (1993) Lactate disposal in resting trained and untrained forearm skeletal muscle during high intensity leg exercise. Eur J Appl Physiol Occup Physiol 67(4):360-366. (Pubitemid 23320364)
8. Savard G, et al. (1987) Noradrenaline spillover during exercise in active versus resting skeletal muscle in man. Acta Physiol Scand 131(4):507-515. (Pubitemid 18066320)
9. Apró W, Blomstrand E (2010) Influence of supplementation with branched-chain amino acids in combination with resistance exercise on p70S6 kinase phosphorylation in resting and exercising human skeletal muscle. Acta Physiol (Oxf) 200(3):237-248.
10. Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: Focus on musclederived interleukin-6. Physiol Rev 88(4):1379-1406.
11. Lichtenstein L, et al. (2007) Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL-and HL-dependent hepatic cholesterol uptake. Arterioscler Thromb Vasc Biol 27(11):2420-2427. (Pubitemid 350203959)
12. Sukonina V, Lookene A, Olivecrona T, Olivecrona G (2006) Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue. Proc Natl Acad Sci USA 103(46):17450-17455. (Pubitemid 44788989)
13. Yoshida K, Shimizugawa T, Ono M, Furukawa H (2002) Angiopoietin-like protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 43(11):1770-1772. (Pubitemid 35315796)
14. Wang H, Eckel RH (2009) Lipoprotein lipase: From gene to obesity. Am J Physiol Endocrinol Metab 297(2):E271-E288.
15. Georgiadi A, et al. (2010) Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress. Circ Res 106(11):1712-1721.
16. Kersten S, et al. (2009) Caloric restriction and exercise increase plasma ANGPTL4 levels in humans via elevated free fatty acids. Arterioscler Thromb Vasc Biol 29(6):969-974.
17. Robciuc MR, et al. (2012) Angiopoietin-like 4 mediates PPAR delta effect on lipoprotein lipase-dependent fatty acid uptake but not on beta-oxidation in myotubes. PLoS ONE 7(10):e46212.
18. Staiger H, et al. (2009) Muscle-derived angiopoietin-like protein 4 is induced by fatty acids via peroxisome proliferator-activated receptor (PPAR)-delta and is of metabolic relevance in humans. Diabetes 58(3):579-589.
19. Kristensen JM, et al. (2007) Absence of humoral mediated 5'AMP-activated protein kinase activation in human skeletal muscle and adipose tissue during exercise. J Physiol 585(Pt 3):897-909. (Pubitemid 350278723)
20. Mascher H, Ekblom B, Rooyackers O, Blomstrand E (2011) Enhanced rates of muscle protein synthesis and elevated mTOR signalling following endurance exercise in human subjects. Acta Physiol (Oxf) 202(2):175-184.
21. Koliwad SK, et al. (2009) Angiopoietin-like 4 (ANGPTL4, fasting-induced adipose factor) is a direct glucocorticoid receptor target and participates in glucocorticoidregulated triglyceride metabolism. J Biol Chem 284(38):25593-25601.
22. Nilsson EC, et al. (2006) Opposite transcriptional regulation in skeletal muscle of AMPactivated protein kinase gamma3 R225Q transgenic versus knock-out mice. J Biol Chem 281(11):7244-7252. (Pubitemid 43847492)
23. Mu J, Brozinick JT, Jr., Valladares O, Bucan M, Birnbaum MJ (2001) A role for AMPactivated protein kinase in contraction-and hypoxia-regulated glucose transport in skeletal muscle. Mol Cell 7(5):1085-1094. (Pubitemid 32525754)
24. Mandard S, et al. (2006) The fasting-induced adipose factor/angiopoietin- like protein 4 is physically associated with lipoproteins and governs plasma lipid levels and adiposity. J Biol Chem 281(2):934-944.
25. Kroupa O, et al. (2012) Linking nutritional regulation of Angptl4, Gpihbp1, and Lmf1 to lipoprotein lipase activity in rodent adipose tissue. BMC Physiol 12:13.
26. Bartelt A, et al. (2011) Brown adipose tissue activity controls triglyceride clearance. Nat Med 17(2):200-205.
27. Schrauwen-Hinderling VB, et al. (2003) Intramyocellular lipid content is increased after exercise in nonexercising human skeletal muscle. J Appl Physiol (1985) 95(6): 2328-2332. (Pubitemid 37444975)
28. Lichtenstein L, et al. (2010) Angptl4 protects against severe proinflammatory effects of saturated fat by inhibiting fatty acid uptake into mesenteric lymph node macrophages. Cell Metab 12(6):580-592.
29. Bergeron R, et al. (2001) Effect of 5-aminoimidazole-4-carboxamide-1- beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats. Diabetes 50(5):1076-1082. (Pubitemid 32374538)
30. Buhl ES, et al. (2002) Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51(7):2199-2206. (Pubitemid 34729025)
31. An D, et al. (2005) The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase. Am J Physiol Endocrinol Metab 288(1):E246-E253. (Pubitemid 40023814)
32. Hauton D (2011) Does long-term metformin treatment increase cardiac lipoprotein lipase? Metabolism 60(1):32-42.
33. Ohira M, Miyashita Y, Murano T, Watanabe F, Shirai K (2009) Metformin promotes induction of lipoprotein lipase in skeletal muscle through activation of adenosine monophosphate-activated protein kinase. Metabolism 58(10):1408-1414.
34. Enevoldsen LH, Simonsen L, Bülow J (2005) Postprandial triacylglycerol uptake in the legs is increased during exercise and post-exercise recovery. J Physiol 568(Pt 3): 941-950. (Pubitemid 41646033)
35. Hamilton MT, Etienne J, McClure WC, Pavey BS, Holloway AK (1998) Role of local contractile activity and muscle fiber type on LPL regulation during exercise. Am J Physiol 275(6 Pt 1):E1016-E1022.
36. Vissing K, Andersen JL, Schjerling P (2005) Are exercise-induced genes induced by exercise? FASEB J 19(1):94-96. (Pubitemid 40069929)
37. Hardman AE (1998) The influence of exercise on postprandial triacylglycerol metabolism. Atherosclerosis 141(Suppl 1):S93-S100.
38. Seip RL, Semenkovich CF (1998) Skeletal muscle lipoprotein lipase: Molecular regulation and physiological effects in relation to exercise. Exerc Sport Sci Rev 26:191-218. (Pubitemid 128461557)
39. Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: Skeletal muscle as a secretory organ. Nat Rev Endocrinol 8(8):457-465.
40. Pillon NJ, Bilan PJ, Fink LN, Klip A (2013) Cross-talk between skeletal muscle and immune cells: Muscle-derived mediators and metabolic implications. Am J Physiol Endocrinol Metab 304(5):E453-E465.
41. Nilsson SK, et al. (2012) Triacylglycerol-rich lipoproteins protect lipoprotein lipase from inactivation by ANGPTL3 and ANGPTL4. Biochim Biophys Acta 1821(10):1370-1378.
42. Schrauwen-Hinderling VB, et al. (2003) The increase in intramyocellular lipid content is a very early response to training. J Clin Endocrinol Metab 88(4):1610-1616. (Pubitemid 36623377)
43. Schrauwen P, et al. (2002) The effect of a 3-month low-intensity endurance training program on fat oxidation and acetyl-CoA carboxylase-2 expression. Diabetes 51(7): 2220-2226. (Pubitemid 34729028)
44. Schrauwen P, et al. (2002) Effect of acute exercise on uncoupling protein 3 is a fat metabolism-mediated effect. Am J Physiol Endocrinol Metab 282(1):E11-E17. (Pubitemid 34654100)
45. Hoeks J, et al. (2010) Prolonged fasting identifies skeletal muscle mitochondrial dysfunction as consequence rather than cause of human insulin resistance. Diabetes 59(9):2117-2125.
46. Hoeks J, et al. (2003) Effect of beta1-and beta2-adrenergic stimulation on energy expenditure, substrate oxidation, and UCP3 expression in humans. Am J Physiol Endocrinol Metab 285(4):E775-E782. (Pubitemid 37176428)
47. Alex S, et al. (2013) ANGPTL4 is produced by entero-endocrine cells in the human intestinal tract. Histochem Cell Biol, 10.1007/s00418-013-1157-y. 48. Goh YY, et al. (2010) Angiopoietin-like 4 interacts with integrins beta1 and beta5 to modulate keratinocyte migration. Am J Pathol 177(6):2791-2803.
48. Jong MC, et al. (1997) Reduced very-low-density lipoprotein fractional catabolic rate in apolipoprotein C1-deficient mice. Biochem J 321(Pt 2):445-450. (Pubitemid 27056493)
49. Rensen PC, et al. (1997) Particle size determines the specificity of apolipoprotein E-containing triglyceride-rich emulsions for the LDL receptor versus hepatic remnant receptor in vivo. J Lipid Res 38(6):1070-1084. (Pubitemid 27281803)
50. Teusink B, et al. (2003) Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 52(3):614-620. (Pubitemid 36323566)
51. Sparks LM, et al. (2011) Remodeling lipid metabolism and improving insulin responsiveness in human primary myotubes. PLoS ONE 6(7):e21068.